None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Health System, Gangnam Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Criteria for selection of clinical trial group and clinical control group 1) Male and female who have agreed to participate in the study of persons aged 19 years or older and 50 years or younger 2) Those who score at least 7 points in the PHQ-9 test in the first-line online mental health screening evaluation (PHQ-9) 3) Depressive symptom evaluation scale (K-QIDS-SR) score of 11 points or more in the second stage in-depth evaluation 4) Subjects who reported suicidal tendency score between 2 and 9 in the third step offline precise evaluation. A healthy control group 1) Male and female who have agreed to participate in the study of persons aged 19 years or older and 50 years or younger 2) Depression screening test score of less than 5 points in the first stage online mental health screening (PHQ-9) 3) Depressive symptom evaluation scale (K-QIDS-SR) score of 5 points or less in the second step in-depth evaluation 4) Subjects with a suicidal tendency score of 1 or less in the third step offline precise evaluation. 5) Subjects who do not qualify for significant psychiatric diagnosis in each module of the MINI international Neuropsychiatric Interview
Exclusion criteria
Exclusion criteria: 1) Those who have difficulty in using virtual reality (VR) equipment 2) Subjects who scored below 3 points In the second in-depth screening evaluation of the basic comprehension capacity. 3) Subjects who score more than 10 points on the suicidal tendency evaluation score in the third step offline precise evaluation (We are going to provide crisis intervention for these subjects excluding participation in research and recommending psychiatric intensive treatment including medication and psychotherapy.) 4) Subjects who meet the level of intellectual disability in the short-form intelligence test (sectioning & common sense) 5) Anyone whose risk of suicide is so high that it is difficult to participate in the clinical trial by self-report or clinician evaluation during the test period is going to be withdrawn, and intensive psychiatric treatment including crisis intervention and medication treatment is carried out. 6) Subjects with difficulty or limitations in MRI examination (eg, those with claustrophobia, pacemakers, or metallic surgical clips, or cochlear implants, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Korean version of quick inventory of depressive symptomatology (self-report) | — |
Secondary
| Measure | Time frame |
|---|---|
| suicidal tendency (Mini International Neuropsychiatric Interview, Module C);Columbia-suicide severity rating scale (C-SSRS);Personality Assessment Inventory - borderline features | — |
Countries
Korea, Republic of
Contacts
Public ContactJeong-Ho Seok
Yonsei University Health System, Gangnam Severance Hospital
Outcome results
None listed